Adjuvant chemotherapy uptake in non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 3, Issue 11, 2008, Pages 1272-1278

  Younis, Tallal ^a,b   Al Fayea, Turki ^a,b   Virik, Kiran ^a,b   Morzycki, Wojciech ^a,b   Saint Jacques, Nathalie ^c  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c Surveillance and Epidemiology Unit   (Canada)

Author keywords

Adjuvant chemotherapy; Non small cell lung cancer; Treatment uptake

Indexed keywords

CARBOPLATIN; CISPLATIN; NAVELBINE; PACLITAXEL; PLATINUM; PLATINUM COMPLEX;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANADA; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CONSULTATION; CONTROLLED STUDY; FEMALE; HEALTH CENTER; HUMAN; INCOME; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; ONCOLOGY; PATIENT REFERRAL; PRIORITY JOURNAL; SURGEON; LUNG TUMOR; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY;

AGED; CANADA; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; NOVA SCOTIA; ORGANOPLATINUM COMPOUNDS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 58949103541     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318189f562     Document Type: Article

References (38)

1. Early Breast Cancer Trialists' Collaborative Group (EBCTCG): effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 2005;365:1687-1717.
2. Wolpin BM, Meyerhardt JA, Mamon HJ, et al. Adjuvant treatment of colorectal cancer. CA Cancer J Clin 2007;57:168-185.
3. Hotta K, Matsuo K, Ueoka H, et al. Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials. J Clin Oncol 2004;22: 3860-3867.
4. Sedrakyan A, Van Der Meulen J, O'Byrne K, et al. Postoperative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 2004;128:414-419.
5. Pignon JP, Triboder GV, Scagliotti G, et al. Lung Adjuvant Cisplatin Evaluation (LACE): a pooled analysis of five randomized clinical trials including 4,584 patients. J Clin Oncol 2006;24(18 Suppl):366S (abstr. #7008).
6. Harlan LC, Abrams J, Warren JL, et al. Adjuvant therapy for breast cancer: practice patterns of community physicians. J Clin Oncol 2002; 20:1809-1817.
7. Du X, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data. J Clin Oncol 2001; 19:1455-1461.
8. Du X, Key C, Osborne C, et al. Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer. Ann Intern Med 2003;138:90-97.
9. Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005;97:1407-1427.
10. Schrag D, Gelfand SE, Bach PB, et al. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results-medicare. J Clin Oncol 2001;19:3712-3718.
11. Ong S, Watters JM, Grunfeld E, et al. Predictors of uptake of adjuvant therapy in CRC. Can J Surg 2005;48:225-229.
12. Jessup JM, Stewart A, Greene FL, et al. Adjuvant chemotherapy for stage iii colon cancer: implications of race/ethnicity, age, and differentiation. JAMA 2005;294:2703-2711.
13. Potosky AL, Harlan LC, Kaplan RS, et al. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 2002;20:1192-1202.
14. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant therapy for CRC in a population-based cohort. J Clin Oncol 2003;21:1293-1300.
15. American Society of Clinical Oncology. Clinical Practice Guidelines (http://www.asco.org).
16. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology (http://www.ncccn.org).
17. Keller SM, Adak S, Wanger H, et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected Stage II or IIIA non-small cell lung cancer (Eastern Cooperative Oncology Group). N Engl J Med 2000;343:1217-1222.
18. Scagliotti GV, Fossati R, Torri V, et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. J Natl Cancer Inst 2003;95:1453-1461.
19. Waller D, Peake MD, Stephens RJ, et al. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. Eur J Cardiothorac Surg 2004;26:173-182.
20. Arriagada R, Bergman B, Dunant A, et al. (for The International Adjuvant Lung Cancer Trial Collaborative Group). Cisplatin based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-360.
21. Winton TL, Livingstan R, Johnson D, et al. A prospective randomized trial of adjuvant vinorelbine (VNR) and cisplatin (CIS) in completely resected stage Ib and II non small cell lung cancer (NSCLC) Intergroup JBR 10. N Engl J Med 2005;352:2589-2597.
22. Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006;7:719-727.
23. Strauss GM, Hernden J, Maddaus MA, et al. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage Ib Non-Small Cell Lung Cancer (NSCLC): report of cancer and leukemia group B (CALGB) protocol 9633. J Clin Oncol 2004;22: 621S (abstr. #7019).
24. Strauss GM, Hernden J, Maddaus MA, et al. Adjuvant chemotherapy in Stage IB non-small cell lung cancer (NSCLC): update on Cancer and Leukemia Group B (CALGB) protocol 9633. J Clin Oncol 2006;24(18 Suppl):365S (abstr. #7007).
25. Pisters KM, Evans WK, Azzoli CG, et al. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol 2007;25:5506-5518.
26. Wakelee H, Dubey S, Gandara D. Optimal adjuvant therapy for non-small cell lung cancer-how to handle stage I disease. Oncologist 2007;12:331-337.
27. Saint-Jacques N, Rayson D, Al-Fayea T, et al. Waiting times in early-stage non-small cell lung cancer (NSCLC). J Thorac Oncol 2008;3:865-870.
28. O'Gorman TW, Woolson RF. Variable Selection to Discriminate Between Two Groups: Stepwise Logistic Regression or Stepwise Discriminant Analysis? In The American Statistician: American Statistical Association, 1991. Pp. 187-193.
29. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-1717.
30. SEER: Surveillance, Epidemiology, and End Results Program. National Cancer Institute. Cancer Statistics 2005 (www.seer.cancer.gov). Accessed October 10, 2008.
31. American Cancer Society: Cancer Facts and Figures 2006. Atlanta, GA, American Cancer Society, 2006 (http://americancancersociety.org). Accessed October 10, 2008.
32. Canadian Cancer Society, National Cancer Institute of Canada. Canadian Cancer Statistics, 2007. Toronto, Canada 2007 (www.cancer.ca). Accessed October 10, 2008.
33. Fisher B. Highlights from recent National Surgical Adjuvant Breast and Bowel Project studies in the treatment and prevention of breast cancer. CA Cancer J Clin 1999;49:159-177.
34. Du XL, Jones DV, Zhang D. Effectiveness of adjuvant chemotherapy fornode-positive operable breast cancer in older women. J Gerontol A Biol Sci Med Sci 2005;60:1137-1144.
35. Giordano SH, Duan Z, Kuo Y-F, et al. Use and outcomes of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol 2006; 24:2750-2756.
36. Gridelli C. The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study. Oncologist 2001;1:(6 Suppl) 4-7.
37. Pepe C, Hasan B, Winton T, et al. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR. 10. J Clin Oncol 2007;25:1553-1561.
38. Kassam F, Shepherd FA, Johnston M, et al. Referral patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. J Thorac Oncol 2007;2:39-43.